-
SRPT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Sarepta Therapeutics (SRPT)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.12 bn | 1.12 bn | 1.12 bn | 1.12 bn | 1.12 bn | 1.12 bn |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) | 17.15 mm |
Cash used (since last report) | n/a | n/a | n/a | n/a | n/a | 39.34 mm |
Cash remaining | n/a | n/a | n/a | n/a | n/a | 1.08 bn |
Runway (months of cash) | n/a | n/a | n/a | n/a | n/a | 62.9 |
13F holders | Current |
---|---|
Total holders | 459 |
Opened positions | 77 |
Closed positions | 77 |
Increased positions | 153 |
Reduced positions | 157 |
13F shares | Current |
---|---|
Total value | 10.03 tn |
Total shares | 87.93 mm |
Total puts | 1.20 mm |
Total calls | 1.42 mm |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 11.19 mm | $1.36 tn |
Vanguard | 9.09 mm | $1.10 tn |
Capital International Investors | 8.70 mm | $1.06 tn |
JHG Janus Henderson | 4.33 mm | $526.20 bn |
STT State Street | 4.07 mm | $494.85 bn |
Farallon Capital Management | 2.87 mm | $348.37 bn |
Avoro Capital Advisors | 2.56 mm | $310.73 bn |
BK The Bank of New York Mellon Corporation | 2.15 mm | $260.87 bn |
Wellington Management | 2.07 mm | $251.54 bn |
JPM JPMorgan Chase & Co. | 2.02 mm | $245.69 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Mar 25 | Cristin Rothfuss | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 296 | 30.00 k | 13,325 |
4 Mar 25 | Cristin Rothfuss | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 288 | 29.19 k | 13,037 |
4 Mar 25 | Bilal Arif | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 233 | 23.61 k | 16,282 |
4 Mar 25 | Bilal Arif | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 281 | 28.48 k | 16,515 |
4 Mar 25 | Dallan Murray | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 1,685 | 170.76 k | 19,821 |
4 Mar 25 | Ian Michael Estepan | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 1,370 | 138.84 k | 44,956 |
4 Mar 25 | Louise Rodino-Klapac | Common Stock | Payment of exercise | Dispose F | No | No | 101.34 | 1,704 | 172.68 k | 65,322 |